All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Loss of People Living with HIV/AIDS in the Care Centers of Kinshasa, Democratic Republic of the Congo

DOI: 10.4236/oalib.1109729, PP. 1-7

Subject Areas: HIV

Keywords: Loss of Sight, PLHIV, Kinshasa, DRC

Full-Text   Cite this paper   Add to My Lib

Abstract

Context: The retention of People Living with HIV (PLHIV) and on Antiretroviral (ARV) in Outpatient Treatment Centers (OTC) remains a major challenge in Africa, particularly in cross-border areas due to the high mobility of the population. Objective: The objective of this study was to determine the reasons behind the loss of patients on Antiretroviral Treatment (ART) after 6 months of follow-up. Methods: This study is a descriptive survey to present the reasons for the loss of PLHIV at the 6th month of ART in the OTC for HIV in Kinshasa. The population of the present study was HIV-infected adults over the age of 18 on first-line ART in the OTCs included in the study. The parameters of interest followed for the present study were: age, sex, clinical condition and reasons for loss of PLHIV. Results: At the sixth-month medical follow-up appointment, 62 patients had responded and were thus included; 61.3% were women and 38.7% were men. The loss of patient’s rate from D0 to M6 was 47.9%. 61.8% of patients were at clinical stage 3 according to WHO, followed by 29.1% of patients who were in clinical stage 1. 67.9% had normal clinical status and 28.3% had good clinical status. The most common reasons were respectively travel and lack of contact for 10.5% each; followed respectively by non-respect of appointment dates and fear of blood samplings for 8.8%, each, and forgetfulness for 7.0%. Conclusion: Nearly half of the patients no longer return to the treatment centers where they started. The most common reasons for not keeping appointments are travel, lack of contact, not keeping appointment dates, fear of blood samples and forgetfulness.

Cite this paper

Bongenya, B. I. , Dikati, N. M. , Losenga, L. O. , Selenge, S. M. , Booto, G. I. , Ntumba, T. K. , Kabengele, B. O. , Sombo, M. A. S. , Bumoko, G. M. M. and Kamangu, E. N. (2023). Loss of People Living with HIV/AIDS in the Care Centers of Kinshasa, Democratic Republic of the Congo. Open Access Library Journal, 10, e9729. doi: http://dx.doi.org/10.4236/oalib.1109729.

References

[1]  Badji, A. (2014) Etude sur les problèmes des perdus de vue dans le suivi des PVVIH dans les zones transfrontalières entre la Gambie, le Sénégal et la guinée Bissau.
[2]  Branson, B.M. (2007) State of the Art for Diagnostics of HIV Infection. Clinical Infectious Diseases, 45, 221-225. https://doi.org/10.1086/522541
[3]  ONUSIDA (2010) Rapport Mondial: rapport sur l’épidémie mondiale de SIDA 2010. https://www.unaids.org/globalreport/Global_report_fr.htm
[4]  Bernede, M. (2012) Les perdus de vue en Afrique : Quelles réponses? Transversal n° 57 marsavril repères.
[5]  Drabo, M., Coulibaly, D.S., Mallé, M., Gaudart, J. and Boyer, S. (2018) Facteurs associes au perdu de vue (PDV) chez les patients infectes par le VIH sous traitement antirétroviral (TARV) au Centre de Traitement Ambulatoire (CTA) de ONG Walé Segou, Mali. Mali Médical, hal-02118536.
[6]  Toma, S., Sartori, M., Weber, K., Carruto, A., Moayedoddin, B., Toutous, L., Trellu, M., Calmy, A., Pichard, C. and Joly, C. (2014) Bénéfices d’un accompagnement psychologique des patients vivant avec le VIH. Revue Médicale Suisse, 9, 374-377.
[7]  Organisation Mondiale de la Santé (2015) VIH/SIDA: Cadre d’action dans la région africaine de l’OMS pour 2016-2020.
[8]  Programme National Multisectoriel de Lutte contre le VIH/SIDA (PNMLS), Présidence de la République, République Démocratique du Congo (2021) Rapport GAM.
[9]  Dépistage et confirmation de la séropositivité. http://mediatheque.lecrips.net/docs/PDF_GED/S59217.pdf
[10]  Programme National de Lutte contre le VIH/SIDA et Infections Sexuellement Transmissible (PNLS) (2014) Ministère de la Santé Publique et Hygiène, République Démocratique du Congo. Rapport Annuel.
[11]  Kamangu, E.N., Bulanda, B.I., Bongenya, B.I., Kateba, E.T., Okonda, M.O., Kasongo, V.N. and Kingombe, M.A. (2019) Evaluation of the Efficacy of the Phyto-Drug Djovikas: Traditional Treatment against HIV Infection. ARC Journal of AIDS, 4, 1-4.
[12]  Buju, R.T., Akilimali, P.Z., Kamangu, E.N., Mesia, G.K., Kayembe, J.M.N. and Situakibanza, H.N. (2022) Incidence and Predictors of Loss to Follow up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study. International Journal of Environmental Research and Public Health, 19, Article 4631. https://doi.org/10.3390/ijerph19084631
[13]  Opio, D., Semitala, F.C., Kakeeto, A., Sendaula, E., Okimat, P., Nakafeero, B., Nankabirwa, J.I., Karamagi, C. and Kalyango, J.N. (2019) Loss to Follow-Up and Associated Factors among Adult People Living with HIV at Public Health Facilities in Wakiso District, Uganda: A Retrospective Cohort Study. BMC Health Services Research, 19, Article No. 628. https://doi.org/10.1186/s12913-019-4474-6
[14]  Ba, S., Ba, N., Sembene, L., Dia, H., Ndiaye, J., Dia, N. and Ndour, C. (2020) Prévalence et facteurs associes a la non-rétention aux soins des Personnes Vivant avec le VIH (PVVIH) suivies dans un site de prise en charge décentralisé. Médecine et Maladies Infectieuses, 50, S187. https://doi.org/10.1016/j.medmal.2020.06.401
[15]  Unal, G., Lesourd, A., Theron, D., Guillois, C., Debab, Y. and Etienne, M. (2019) Personnes Vivant avec le VIH perdues de vue: Peuton anticiper? Médecine et Maladies Infectieuses, 49, S149-S150. https://doi.org/10.1016/j.medmal.2019.04.361
[16]  Kamangu, N.E., Bulanda, I.B., Bongenia, I.B., Botomwito, T.H., Mvumbi, L.G., De Mol, P., Vaira, D., Hayette, M.P. and Kalala, L.R. (2015) Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa. Open Access Library Journal, 2, e1564. https://doi.org/10.4236/oalib.1101564
[17]  Kamangu, E.N. (2018) Estimation of Clinical, Immunological and Virological Failure of First Line Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 5, e4560. https://doi.org/10.4236/oalib.1104560
[18]  Kamangu, N.E., Kawila, M.E., Mukumbi, H. and Mvumbi, L.G. (2012) Estimated Rates of Treatment Failure in First-Line Antiretroviral Treatment in Kinshasa: Case of the ACS AMO-Congo. International Journal of Collaborative Research on Internal Medicine & Public Health, 4, 885-891.
[19]  Sidibé, A.S. (2014) Le devenir des patients adultes VIH (positifs) 6 mois après initiation au traitement antirétroviral. Thèse doctorale en Pharmacie. Faculté de Pharmacie, Université des Sciences des Techniques et des Technologies de Bamako.
[20]  Essomba, E.N., Beyiha, G., Nida, M., Abessouguie, I.J., Kouo, N.M. and Lehman, L. (2014) Profil épidémiologique des perdus de vue sous antirétroviraux: Cas de l’hôpital Laquintinie de Douala. Revue de Médecine et de Pharmacie, 4.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413